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Highlights: 
 
1. The infusion of NMDA induced degeneration of hippocampal principal cells. 
2. Neurodegeneration was accompanied with progressive and severe neuroinflammation. 
3. The lesion did not induce loss of GABAergic interneurons. 
4. GluN1 and GluN2B subunits of NMDA receptor were upregulated at early time points. 
5. GABAA receptor α5 subunit was downregulated at 30 days after the lesion. 
 
 
ABSTRACT 
 
Excessive stimulation of NMDA receptors with glutamate or other potent agonists such as 
NMDA leads to excitotoxicity and neural injury. In this study, we aimed to provide insight 
into an animal model of brain excitotoxic damage; single unilateral infusion of NMDA at mild 
dose into the hippocampal formation. NMDA infusion induced chronic, focal 
neurodegeneration in the proximity of the injection site. The lesion was accompanied by 
severe and progressive neuroinflammation and affected preferentially principal neurons while 
sparing GABAergic interneurons. Furthermore, the unilateral lesion did not cause significant 
impairment of spatial learning abilities. Finally, GluN1 and GluN2B subunits of NMDA 
receptor were significantly upregulated up to 3 days after the NMDA infusion, while GABAA 
α5 subunit was downregulated at 30 days after the lesion. Taken together, a single infusion of 
NMDA into the hippocampal formation represents an animal model of excitotoxicity-induced 
chronic neurodegeneration of principal neurons accompanied by severe neuroinflammation 
and subunit specific changes in NMDA and GABAA receptors. 
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1. INTRODUCTION 
N-methyl-D-aspartate (NMDA) receptors are a sub-family of glutamate-gated ion channels, 
the most abundant receptors in mammalian brain responsible for mediating excitatory 
neurotransmission. They are blocked with Mg2+ at membrane potential, require co-activation 
by glutamate and glycine (or D-serine) and are a major gate for Ca2+-induced postsynaptic 
signaling. Native NMDA receptors consist of two GluN1 and either two GluN2 or GluN3 
subunits. The GluN1 subunit is necessary for the assembly of functional NMDA receptors 
(Zukin and Bennett, 1995). Furthermore, the receptor can have many isoforms (GluN1 has 8 
different splice variants, GluN2A, B, C, D; GluN3A, B) with diverse brain localization and 
function (Sheng and Kim, 2002). NMDA receptors are important in brain development, 
generation of rhythms, neural plasticity, memory, learning and neuroprotection (Paoletti and 
Neyton, 2007; Cull-Candy et al., 2001). 
Excessive stimulation of NMDA receptors with glutamate or other potent agonists such as 
NMDA leads to excitotoxicity (Sattler and Tymianski, 2001). This process is characterized 
by massive depolarization of postsynaptic membrane, leading to influx of water, Na+ and Cl- 
ions, osmotic imbalance and possible breakdown of the cell. Excitotoxicity also increases 
intracellular calcium levels leading to enhanced free radical formation, activation of 
phospholipases, endonucleases and proteases and subsequent cell damage or death. 
Excitotoxicity occurs in a number of pathological conditions such as stroke and ischemia 
(Lai et al., 2014), traumatic brain injury (Caccamo et al., 2004), as well as neurodegenerative 
diseases (Mehta et al., 2013).  
Infusion of NMDA into the brain parenchyma has been utilized as an animal model of 
excitotoxicity to induce structure-specific damage of nervous tissue (White et al., 2003; 
Wallace and Whishaw, 2003, Maren et al., 1997 1999). This approach has also been used 
extensively by behavioral neuroscientists to study the role of different brain regions in 
cognitive processing; especially, the role of hippocampus in learning and memory (Kim and 
Frank, 2009; Dillon at al., 2008; Maren et al., 1997; Sparks et al., 2011). Additionally, this 
model has been utilized to induce chronic neuroinflammation (Battle et al., 2015) and to test 
the efficacy of neuroprotective drugs (Rambousek et al., 2011). Furthermore, systemic 
administration of NMDA has been utilized to elicite epileptic motor seizures in developing as 
well as in young adult rats (Mares and Velisek, 1992). 
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It is well described that NMDA infusion into the hippocampal formation induces loss of 
pyramidal cells and dentate gyrus granule cells (Jarrard, 2002). The extent and severity of the 
hippocampal lesion depends on the dose and the number of injections. With very low doses, 
it is possible to induce damage of a few neurons in focal area whereas high doses are able to 
lesion a large amount of tissue (White et al., 2003; Wallace and Whishaw, 2003). Intra-
hippocampal infusion of NMDA also induces severe seizures during the hours after 
application (Zaczek and Coyle, 1981) in adult rats. However, to our knowledge there is no 
report investigating the effect of hippocampal NMDA lesions in adult animals on seizure 
activity on a longer time axis.  
The changes induced by NMDA infusion, such as expression of NMDA and GABAA 
receptors subunits or cell-specific injury, have received little attention so far. Therefore, we 
aimed to further characterize this model of excitotoxic damage in adult rats. We 
characterized immunohistochemically the changes induced by unilateral infusion of 1 µL of 
25 mM NMDA into the hippocampus at 1, 3, 7 and 30 days post-injection (dpi). First, we 
determined the effect of NMDA on neuronal degeneration and spatial learning abilities. 
Then, we characterized the temporal progression of neuroinflammation using antibodies 
against microglial marker Iba-1 and astrocytic marker glial fibrillary acidic protein (GFAP). 
Since previous reports hypothesized that GABAergic interneurons tolerate excitotoxic insults 
(Avigone et al., 2005), we evaluated effect of NMDA lesion also on populations of 
interneurons expressing the calcium binding proteins parvalbumin, calretinin, calbindin, as 
well as the neuropeptide Y (NPY). Finally, we investigated immunohistochemically the 
temporal progression of changes in expression of major NMDA (GluN1, GluN2B) and 
GABAA (α1, α2, α5 and γ2) receptor subunits. We show that NMDA infusion induces long-
lasting degeneration of glutamatergic neurons leaving GABAergic interneurons unaffected 
and causes subunit-specific changes in expression of NMDA and GABAA receptors.  
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2. METHODS 
Animals and intra-hippocampal NMDA infusion 
We utilized three months old male Long-Evans rats from the breeding colony of Institute of 
Physiology of the Academy of Sciences of the Czech Republic (CZ 11760353). All animals were 
anaesthetized with isoflurane 3.5% (Abbot Laboratories, UK) in a specialized induction 
chamber. During surgery, animals were fixed using a stereotactic apparatus (TSE systems, 
Germany) and anaesthetized with isoflurane 1.5 - 2%, propelled by atmospheric air. Small 
opening in the skull was made using a micro-drill (Dremel, USA) and subsequently 1 µL of 25 
mM NMDA (Sigma Aldrich, Germany) or 10 mM of sterile PBS (sham group; Sigma Aldrich, 
USA) was applied unilaterally at a flow rate of 0.2 µL/min into the dorsal left hippocampus with 
a pump (TSE, model 540310 plus) and 2 min after the end of infusion the needle (#7635-01, 
Hamilton) was retracted. To prevent the loss of tissue integrity that was reported in previous 
studies (White et al., 2003; Wallace and Whishaw, 2003), we utilized mild (25 mM) 
concentration of NMDA in this experiment. The application coordinates (−4 mm AP from 
bregma, +2.5 mm ML and 4.8 mm below the skull surface) were measured in relation to a 
stereotaxic atlas (Paxinos and Watson, 1998). For the evaluation of spatial learning abilities of 
rats we used also higher dose of NMDA (50 mM) and bilateral infusion. 
The NMDA (#M3262, Sigma Aldrich, USA) working solution was prepared in 10 mM PBS 
(Sigma Aldrich, USA), pH adjusted to 7.4, fractioned in a small volume aliquots (20 µL) and 
stored at -20 °C. A fresh aliquot from the same batch was used for all experiments. Each aliquot 
was used only once. 
Three animals were used for magnetic resonance imaging. Seven to ten animals per group, 
44 in total, were used for behavioral experiment (Carousel maze). Five animals per group were 
used [SHAM and NMDA lesion group x 1, 3, 7 and 30 dpi; 40 in total] for histology 
experiments. In total, we utilized 87 experimental animals in this study. All experimental 
procedures complied with the Animal Protection Code of the Czech Republic, the appropriate 
directive of the European Union (2010/63/EC) and NIH guidelines. 
 
Magnetic resonance (MR) imaging 
MR imaging of animals under general anesthesia (isoflurane 2%) was performed using a 4.7-T 
Bruker spectrometer equipped with a resonator coil. Animals were imaged one day before the 
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lesion and then 1, 3, and 7 days after the intra-hippocampal NMDA infusion. A T2-weighted 
turbospin echo sequence Rapid Acquisition with Relaxation Enhancement [RARE; repetition 
time (TR) = 3,000 ms, effective echo time (TE) = 36.0 ms, turbo factor = 8, number of 
acquisitions (AC) = 4, field of view = 3.5 cm, matrix = 256 × 256, spatial resolution = 137 × 137 
µm2, slice thickness = 0.85 mm, acquisition time = 4 min] was used for measurement of axial 
and coronal images. 
 
Evaluation of spatial learning abilities – Carousel Maze 
The Carousel maze apparatus was described in detail in our previous studies (Stuchlik et al., 
2004, 2013, 2014). Briefly, experimental animals have to avoid to shock sector on rotating 
circular arena. The sector where rats receive mild electric shock is not marked on the arena, thus 
animal have to utilize visual cues in experimental room to learn its position. In other words, 
animals have to choose allothetic strategy in order to successfully solve the task. The number of 
entrances into the to-be-avoided sector (number of errors) measures the efficiency of avoidance 
in the Carousel maze. In this experiment, rats were trained for four consecutive days in 20 min 
long sessions. This training procedure was found to be long enough to induce optimal spatial 
avoidance of the shock sector and the data from the fourth session represents asymptotic levels 
of performance. Thus, only data from session four were analyzed. The training of rats in the 
Carousel maze started 7 days after the infusion of NMDA into hippocampal formation; hence, 
the fourth session took place at day 11 after surgery.  
 
Histology 
At 1, 3, 7 or 30 dpi, rats were anaesthetized with an overdosed mixture of ketamine (Vetoquinol) 
and xylasine (Alfasan) and transcardially perfused at a flow 50 mL/min with 250 mL, 4 °C, 4% 
paraformaldehyde (PFA) in 0.1 M PBS, preceded by a 5 min rinse with 0.01 M PBS. After 
postfixation in the same fixative overnight, the brains were stored in a 1% PFA solution at 4 °C, 
cryoprotected in 10% and consequently 30 % sucrose solution. Brain tissue was stored at -80°C. 
Free-floating sections (40 µm thick) were cut coronally on a sliding microtome (Leica), and 18 
random sampled serial sections were collected from bregma -1.5 to -6.6 mm and stored at - 20°C 
in cryoprotective solution.  
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Fluoro-Jade B staining and scoring of neuronal damage 
Fluoro-Jade B dye, the fluorescin derivative, has been utilized to visualize neuronal injury and 
degeneration (Schmued and Hopkins, 2000). Both the chemical entity of this compound and the 
target component are not identified. However, its specificity for degenerating neurons has been 
validated using a number of neurotoxins. The sections were mounted on Superfrost Plus Gold 
(Thermo) microscope slides and let dry overnight. Then the slides were consequently incubated 
in 100% ethanol for 3 min, 70% ethanol for 3 min, distilled water for 2 min, 0.06 % KMnO4 for 
15 min, distilled water for 2 min, 0.0001 % solution of FJB (Millipore, USA, dissolved in 0.1 % 
glacial acetic acid) for 30 min and finally rinsed three times in distilled water. The slides wwere 
air-dried, immersed to xylene and coverslipped with DPX mounting media (Thermo). Brain 
sections were imaged using a microscope (AxioVision Imaginer Z1; Zeiss, Germany) equipped 
with a digital camera. Alexa 448 filter was used. Extent of damage was evaluated separately in 
individual areas of the hippocampal formation, namely CA1, CA3, dentate gyrus, hilus and 
subiculum. The range of damage was expressed as a percentage of hippocampal area with 
Fluoro-Jade B positive neurons. Evaluation scale: 0 – 0-5%, 1 – 6-25%, 2 – 26-50%, 3 – 51-
75%, 4 > 75% Fluoro-Jade B-positive neurons in individual hippocampal area.  
 
Immunohistochemistry 
Immunohistochemistry was performed with one series of brain sections per animal, allowing us 
to analyze each marker under equal conditions for all animals. The primary antibodies used in 
the study are listed in Table 1. The free-floating sections were rinsed in Tris-Triton solution 
(0.05 M Tris, 0.015 NaCl, 0.05 % Triton, pH = 7.4) three times for 10 min, followed by 
overnight incubation in the primary antibodies diluted in Tris-Triton containing 2% normal goat 
serum (NGS), 0.2% TritonX-100 at 4°C on a shaker.  
Sections used for detecting NMDAR GluN1 and GluN2B subunits were additionally 
digested by pepsin before incubating in primary antibodies. This procedure significantly 
improves the detection of membrane proteins (Watanabe et al., 1998). Briefly, the sections were 
incubated at 37°C for 10 min in 0.2 M HCl solution and consequently for additional 10 min in 
0.2 M HCl solution containing 0.15 mg/mL pepsin (Dako, S3002, CA, USA). After washing in 
PBS for 5 min and twice in Tris-Triton for 10 min the sections were incubated in primary 
antibodies.  
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On the second day, the sections were rinsed in three times for 10 min in Tris-Triton, then 
incubated with biotinylated secondary goat antibodies diluted at 1:300 in Tris-Triton containing 
2% normal goat serum (NGS) and 2% rat serum for 30 min at room temperature under 
continuous agitation. After three washing cycles in PBS the sections were incubated in Elite 
ABC Kit (Vector Laboratories Inc., California, USA) diluted in PBS, 0.2% TritonX-100 for 1 h, 
and washed three times for 10 min in Tris-Triton. Secondary antibodies were visualized using 
0.05% solution of 3,3-diaminobenzidine (DAB, Fluka, Switzerland) and 0.01 % H2O2 in Tris-
Triton pH 7.7. A fresh aliquot from same batch was used for each experiment.  The color 
reaction was terminated after 8 min by transferring the sections in ice-cold PBS. To prevent 
intra-group variation, all sections for each marker were stained in one DAB experiment. After 
two additional washes in PBS the sections were mounted on gelatine-coated slides, dried 
overnight, dehydrated and cover slipped with EukittTM mounting media (Sigma Aldrich, 
Germany).  
 
Densitometry 
Densitometry measurements of GABAA and NMDA receptor subunits immunoreactivities were 
measured using ImageJ software (NIH, Maryland, USA). Digital images were acquired with a 
20x objective (NA 0.8 NA air) using a 3-CCD digital color camera (Hitachi HV - F22, 1360 x 
1024 pixels, pixel size 4.65  µm) mounted in an automated upright slide scanning microscope, 
Zeiss Mirax mini slides-canner (Zeiss, Jena, Germany). Acquired images of hippocampus and 
neocortex were then exported at a 5x magnification using Panoramatic viewer (3DHISTECH, 
Hungary). The optical density (OD) for each hippocampus was normalized to the optical density 
of neocortex. The optical density of neocortex did not differ significantly within the groups. Four 
to six regularly-spaced coronal sections from each animal were analyzed. The optical densities 
for each hippocampus were averaged per animal using the following formula: 
 𝑂𝐷 = (𝑂𝐷%&'(')*&+ − 𝑂𝐷-.//'(01/23)%.56 𝑛  
where n is number of sections and OD optical density measured as pixel intensity in a range of 0 
– 255 using ImageJ software.  
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A densitometric segmentation analysis was performed for the anti-GFAP (astroglial marker), 
and anti-Iba1 (activated microglia marker) immunoperoxidase staining to measure the relative 
percentage of the labeled cells covered by the immunoreactive signals in the hippocampal 
formation. The quantification was performed using a developed macro in ImageJ software (NIH, 
Maryland, USA). The pictures obtained with Zeiss Mirax mini slides-canner were converted to 
8-bit images, Gaussian blur filter was applied and the background was subtracted. Next the 
threshold function was applied and relative percentage of the labeled cells covered by the 
immunoreactive signal was automatically calculated.  
Data were analyzed and statistically compared between groups using two-way ANOVA. 
Ipsilateral and contralateral hippocampi were analyzed separately. Staining intensities, 
represented as normalized relative optical densities using 2 x 4 ANOVA design to detect effect 
of group (NMDA lesion or PBS infusion) and day post-injection. Following the confirmation of 
main effects, Bonferroni’s post-hoc tests were performed. Statistical significance was set at P < 
0.05.  
 
Hippocampal volume estimation 
The volume of hippocampus for each animal was estimated from series of sections from 
immunohistochemistry experiments. Twenty-two sections were analyzed from -1.6 to -5.8 cm 
from the bregma. The surface area was measured using ImageJ software (NIH, Maryland, USA). 
Panoramatic viewer determined the absolute scale and pictures were exported including the scale 
mark. Then we set the scale using the “set scale function” in ImageJ. Volumes were calculated 
by multiplying the surface area by the distance between measured sections. Data were analyzed 
and statistically compared between groups using two-way ANOVA as described in the section 
„densitometry“. 
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3. RESULTS 
 
Unilateral intra-hippocampal NMDA induced focal neurodegeneration and increase in T2 
signal 
 
In this experiment, we characterized temporal progression of changes induced by unilateral 
infusion of NMDA into the hippocampal formation. After infusion of NMDA into hippocampal 
formation, all animals suffered from severe seizures lasting two to four hours after surgery. The 
lesion induced severe neurodegeneration of principal glutamatergic neurons, pyramidal and 
granule cells, in dorsal hippocampus and dentate gyrus. The damage of glutamatergic neurons 
remained focal and presumably reflects the diffusion of the injected NMDA solution. One-day 
post injection the Fluoro-Jade B signal was most prominent within cell body and later it 
propagated to axon and dendrites. However, the damage did not spread into the contralateral 
hemisphere or into the ventral part of ipsilateral hippocampal formation. The lesion also did not 
propagate to other brain structures. Fig. 1 shows representative pictures of dorsal ipsilateral 
hippocampal formation 1, 3, 7 and 30 dpi. Sham lesion did not induce neurodegeneration (score 
0). Only minor morphological signs of tissue damage in the proximity of cannula were observed. 
One-way ANOVA did not find significant effect (P > 0.05) in progression of damage score in 
any of studied subfields of hippocampal formation (CA1, CA3, dentate gyrus, hilus and 
subiculum). Interestingly, the severity of neurodegeneration measured as damage score of FJB 
positive cells did not change over 30 days. The neurons affected by NMDA were swollen; 
however, they sustained their basic morphology. Two-way ANOVA also did not find significant 
changes in hippocampal volume after NMDA infusion [NMDA treatment (F(1, 19) = 0.002, P = 
0.9674), dpi (F(19, 19) = 0.8457, P = 0.6406)]; however, we observed mild hippocampal sclerosis 
30 dpi in two animals from five (Fig. 2). The contralateral hippocampus was not affected at any 
of study time-points. To further visualize the extent and progression of the lesion in the same 
animal, we performed MR imaging in three rats. Infusion of NMDA into hippocampus induced 
an increase in T2 signal (Fig. 3) in the hippocampal formation at 1 dpi. The signal decreased 
progressively thereafter; however, it was still detectable at 7 dpi. 
 
Unilateral lesion of hippocampus did not induce a deficit in spatial learning abilities 
The one-way ANOVA did not reveal a significant effect of unilateral intra-hippocampal infusion 
of 25 mM NMDA (P > 0.05). Neither a higher dose of 50 mM induced spatial learning deficits in 
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the Carousel maze (P > 0.05). On the other hand, bilateral infusion of NMDA at both doses (25 
and 50 mM) induced significant (P < 0.05 and P < 0.005, respectively) spatial learning deficit 
measured as number of errors in Carousel Maze. Fig. 4 depicts the number of errors, the 
parameter reflecting spatial learning abilities of rats in the Carousel maze.  
 
NMDA lesion did not affect GABAergic interneurons 
The utilization of specific antibodies against separate populations of GABAergic interneurons 
revealed that NMDA infusion did not induce any apparent loss in hippocampus at any of the 
studied time-points (1, 3, 7, 30 dpi). Representative pictures for 1 dpi are shown at Fig. 5. 
Parvalbumin-, calretinin-, calbindin- and neuropeptide Y- (NPY) positive interneurons were 
unaffected at all studied time points (data not shown).  
 
NMDA lesion induced progressive neuroinflammation 
The infusion of NMDA into the hippocampal formation induced a progressive hypertrophy and 
activation of microglia (Iba-1 immunoreactivity), which persisted also at 30 dpi of NMDA (Fig. 
6). Two-way ANOVA revealed the effect of time (dpi) (F(3, 32) = 4.156, P = 0.0135), treatment 
(F(1, 32) = 51.02, P = 0.0001), as well as their interaction (F(3, 32) = 6.277, P = 0.0018). 
Bonferroni’s multiple comparison tests showed that the NMDA lesion group differs from the 
Sham group at 3, 7 and 30 dpi. Infusion of PBS did not induce activation of microglia. 
Furthermore, the NMDA insult induced significant reactive astrogliosis at all studied time-points 
(Fig. 7). The astroglial scar persisted even at 30 dpi of NMDA. Two-way ANOVA revealed 
effect of time (F(3, 32) = 5.544, P = 0.0035),  treatment (F(1, 32) = 94.41, P < 0.0001), as well as 
their interaction (F(3, 32) = 2.944, P = 0.0477). Bonferroni’s multiple comparison test showed that 
NMDA lesion group differs from PBS group at 1, 3, 7 and 30 dpi. Infusion of PBS induced only 
mild and local astrogliosis at the site of infusion cannula insertion. The increased 
immunoreactivity for both Iba-1 and GFAP was observed in areas positive for the 
neurodegeneration marker Fluoro-Jade B (Supplementary Fig. 2). 
 
NMDA lesion induced changes in expression of NMDA and GABAA receptors subunits 
In the next experiment, we investigated the distribution of NMDAR GluN1 and GluN2B 
subunits in hippocampus. Two-way ANOVA revealed effect of dpi for both subunits (GluN1: 
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F(3, 31) = 5.235, P = 0.0049; GluN2B: F(3, 29) = 4.385, P = 0.0116), treatment (GluN1: F(1, 31) = 
20.81, P < 0.0001; GluN2B: F(1, 29) = 22.87, P < 0.0001) as well as their interaction (GluN1: F(1, 
31) = 20.81, P < 0.0001; GluN2B: F(1, 31) = 1.676, P = 0.2050). Bonferroni’s multiple comparison 
test showed that NMDA lesion group differs from sham lesion group at 1 and 3 dpi for both 
markers. Figures 8 and 9 show the quantification of relative optical density for NMDAR GluN1 
and GluN2B subunits, respectively. The increased immunoreactivity correlated positively with 
FJB positive cells and increased neuroinflammation suggesting that the receptor overexpression 
is occurring in the lesion affected areas. The changes were reversible and already 7 dpi the 
NMDA-lesioned animals did not differ from sham group (P > 0.05). However, representative 
pictures suggest that the overexpression of GluN1 as well as GluN2B subunit persisted in lesion-
affected areas (Fig. 8 and 9, Supplementary Fig. 2). The contralateral hippocampus was not 
affected in any group (Supplementary Fig. 3). Furthermore, we analyzed changes in the 
expression of main GABAA receptor α1 (Fig. 10), α2 (Fig. 11), α5 (Fig. 12) and γ2 subunits (Fig. 
13). NMDA lesion significantly decreased the expression of GABAA receptor α5 subunit 30 dpi 
in ipsilateral hippocampus. Two-way ANOVA revealed effect of dpi (F(3, 29) = 3.243, P = 
0.0363), treatment (F(1, 29) = 5.293, P = 0.0288) as well as their interaction (F(3, 29) = 2.973, P = 
0.0480). Bonferroni’s multiple comparison test showed that NMDA lesion group differs from 
PBS group at 30 dpi. Expression of other subunits was not significantly decreased; however, we 
observed a mild loss of immunoreactivity in lesion-affected regions. The contralateral 
hippocampus was not affected in any group (Supplementary Fig. 3). 
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4. DISCUSSION 
 
Excitotoxins, such as ibotenate, kainate, quisqualate and NMDA have been used to 
replace traditional tissue ablation techniques (Jarrard, 2002; White et al., 2003; Wallace and 
Whishaw, 2003; Hoz et al., 2005). Each excitotoxin interacts with specific subgroup of 
glutamatergic receptors and produces different pattern of damage (Jarrard, 2002). NMDA, the 
excitotoxin used in this study, interacts specifically with NMDA receptors (Watkins and Evans, 
1981). A single unilateral infusion of NMDA into hippocampus induced chronic, focal 
neurodegeneration around the injection site. The lesion was accompanied by severe and 
progressive neuroinflammation and affected preferentially principal neurons leaving GABAergic 
interneurons spared from the damage. We did not observed spread of the damage into the 
contralateral hippocampus or any other structure. Furthermore, the unilateral lesion did not 
induced significant impairment of spatial learning abilities. Finally, GluN1 and GluN2B subunits 
of NMDA receptor were upregulated at 1 and 3 dpi, while GABAA α5 subunit was 
downregulated at 30 dpi. 
 
Unilateral infusion of NMDA induced chronic neurodegeneration of hippocampal principal 
cells 
The single unilateral injection of NMDA into hippocampus affected all cell fields of the 
hippocampus. We did not observe consistently increased FJB staining in any specific subregion 
of hippocampal formation. Compare to kainate lesion of the hippocampus, NMDA lesion does 
not produce a uniform and anatomically defined pattern of damage. Single injection of kainate 
into hippocampus is characterized by loss of hilar neurons, partial loss of CA1 and CA3 and 
progressive dispersion of dentate gyrus (Bouilleret et al., 2000), whereas NMDA lesion damage 
pattern was more variable and presumably followed the spread of injected solution. We also did 
not observe significant hippocampal sclerosis. These data are in accordance with other studies 
investigating the relationship between the damage pattern and receptor density after 
administration of different excitotoxins. NMDA was described to induce damage of all 
hippocampal regions (Jarrard, 2002). However, ex vivo experiments in organotypic slices 
revealed increase vulnerability of CA1, the region of highest NMDA receptor density, followed 
by granule cells and CA3 after NMDA treatment (Kristensen et al., 2001, Vinet et al., 2012). The 
discrepancy between in vivo and ex vivo studies can be explained by the different mode of drug 
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administration. While the NMDA treatment in ex vivo studies allows to apply the drug 
homogenously on the tissue, the extent of stereotactic infusion is determined by the localization 
of injection, volume of the infused solution and the tissue diffusion properties.  
Interestingly, we found large amounts (25 - 50 %) of FJB positive cells even at 30 dpi. 
This finding is important for possible interpretations of behavioral studies using this lesion 
model to “inactivate” hippocampus or any other structure. It seems that NMDA lesion at a mild 
dose is inducing rather chronic neurodegeneration than a fast ablation of the structure. A high 
dose of NMDA and multiple infusion sites are required for the successful tissue ablation (White 
et al., 2003; Wallace and Whishaw, 2003). 
 
The lesion did not spread to other structures and did not induce spatial learning deficit 
At the morphological level, the unilateral infusion of NMDA induced focal damage, leaving 
secondary structures unaffected. We also did not observe conspicuous spread of the damage with 
MR imaging. In this study, bilateral infusion of NMDA into the hippocampus, but not unilateral, 
induced significant spatial learning deficit in Carousel maze at 11 dpi. This further supports our 
finding that the lesion did not affect contralateral hippocampus at morphological level even 
though they are highly interconnected. It seems that contralateral hippocampus is able to 
compensate for the lesioned hippocampus performance. Another explanation for this observation 
might be neural reorganization or partial regeneration of the lesioned hippocampus during the 
recovery phase. In contrast to our present findings, unilateral inactivation of the hippocampal 
formation with tetrodoxin, the sodium channel blocker, is known to induce spatial learning 
deficit in tasks such as Carousel maze (Cimadevilla et al., 2000; Kubik and Fenton, 2005) or 
Morris water maze (Cimadevilla et al., 2005). However, these reports support the finding that 
NMDA induced hippocampal damage does not represent a model to inactivate the structure, but 
rather excitotoxicity triggered neurodegeneration.  
 
NMDA infusion did not affect GABAergic interneurons 
Interestingly, we observed that infusion of NMDA did not affect GABAergic interneurons. 
Neither, immunostaining for parvalbumin-, calbindin-, calretitnin- nor NPY-positive 
interneurons were affected. In the kainate lesion model in mice, immediate loss of parvalbumin 
and calbindin positive interneurons in dentate gyrus and CA1 has been described (Bouilleret et 
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al., 2000). Since we have this model well established in our laboratory, we were able to perform 
the immunostaining under the same conditions and antibodies also with tissue from kainite-
injected animals to have appropriate positive control (data not shown). The loss of calcium-
binding proteins is a strong neurodegeneration indicator of interneurons; however, not ultimate 
evidence. Nevertheless, we did not observe significant changes in expression of GABAA receptor 
α1 subunit, which is the marker of majority of interneurons (Gao and Fritschy, 1994). This is, to 
our knowledge the first report showing a lesser vulnerability of interneurons to NMDA treatment 
at morphological level. However, another study comparing the sensitivity of CA1 pyramidal 
neurons with interneurons of stratum oriens reported that interneurons are more resistant and 
tolerate longer exposure to NMDA (Avignone et al., 2005). Furthermore, they showed that the 
acute toxicity driving the neurodegeneration of pyramidal cells is independent of intracellular 
calcium levels and is rather driven by their greater response to the activation of NMDA receptor. 
It has been also speculated that calcium-binding proteins could buffer Ca2+ and thus protect 
interneurons from its overload. However, knockout experiments (Airaksinen et al., 1997; 
Schwaller et al., 1999) as well as utilization of Ca2+ chelator BAPTA (Avignone et al., 2005) 
failed to prove this hypothesis. Therefore, we hypothesize that the observed ability of 
interneurons to resist NMDA excitotoxicity is caused rather by their different responses to 
NMDA receptor stimulation than the density of expressed NMDA receptors or Ca2+ buffering. 
 
Neurodegeneration was accompanied with progressive neuroinflammation 
Additionally, we found progressive activation of microglia and reactive astrogliosis in lesion-
affected regions. The neuroinflammation persisted even 30 days after the lesion and co-localized 
with ongoing neurodegeneration (Supplementary Fig. 2). Microglia, the brain resident 
macrophages, rapidly respond to the neuronal injury by migration to the site of injury (Kreutberg 
1996), changing their morphology and expression pattern of its surface markers (Greter et al., 
2015), as well as by secretion of a number of signal molecules such as cytokines and 
chemokines. Importantly, hours after the infusion the blood brain barrier is compromised 
allowing monocytes as well as lymphocytes to infiltrate brain parenchyma. Iba-1, the microglia 
marker used in this study, is upregulated during microglia activation; however, it is expressed 
also in resting microglia. Furthermore, Iba-1 is expressed also on macrophages; hence the 
observed immunoreactivity may include also invaded monocyte-derived macrophages. Although, 
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a recent study showed that after kainate lesion the infiltrating myeloid cells (CD11b+/CD45high) 
represent only minor group compare to resident cells (Hong et al., 2010). The activated microglia 
can have protective as well as negative effects on the ongoing neurodegeneration (Heneka et al., 
2014). They are able to remove the damaged neurons and cell debris, protect neurons from 
damage but also induce further neuroinflammation by secretion of pro-inflammatory cytokines 
and other factors. A recent study even showed that ramified microglia plays an active protective 
role against NMDA induced excitotoxicity (Vinet et al., 2012). On the other hand, another study 
showed that microglia expresses functional NMDA receptors that upon activation may trigger 
secretion of factors leading to neuronal death (Kaindl et al., 2012). However, we were not able to 
distinguish their phenotype and role during NMDA induced neurodegeneration with 
immunohistochemistry. Isolation of microglial cells from the site of injury and consequent 
analysis of their surface markers would provide better insight into their particular role in this 
model.  
Additionally, we observed a progressive reactive gliosis characterized by increased 
immunoreactivity of GFAP in lesion-affected regions. It is well known that astrocytes exhibit 
hypertrophy and proliferate at the site of brain injury (Ridet et al., 1997). Similarly to microglia, 
astrocytes can influence the lesion outcome in both directions. Formation of a glial scar is 
changing diffusion parameters and reducing volume of extracellular space (Sykova et al., 1999). 
This leads to increase of local concentration of neurotransmitters, metabolites as well as reactive 
oxygen species. The glial scar can also block ongoing regeneration or sprouting of new axons. 
Although, astrocytes play also an important neuroprotective role. They are capable of scavenging 
oxygen free radicals and they are buffering extracellular K+ and H+, which prevent swelling and 
glutamate release (Chen and Swanson, 2003).  
 
NMDA infusion induced changes in expression of NMDA and GABAA receptors subunits 
NMDA lesion induced changes in optical density of NMDA and GABAA receptors subunits 
immunostaining suggesting changes in their expression. The area of expression changes 
correlated with ongoing neurodegeneration. We found significantly higher optical density of 
immunostaining for GluN1 and GluN2B subunits of NMDAR at 1 and 3 dpi. This finding is very 
surprising considering that the neural tissue should rather protect itself from further excitation. In 
a transient ischemia model, Liu et al. found significantly increased expression of GluN1 subunit 
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with at 24h after reperfusion with gradual decrease afterwards (Liu et al., 2010). Another group 
found increased mRNA levels of GluN1 subunit after kainate injection specifically during status 
epilepticus (Rafiki et al., 1998). It has been also reported that after pilocarpine-induced status 
epilepticus, the GluN1 subunit undergoes rapid relocation to the cell surface enhancing 
excitation in CA3 and DG of rat hippocampus (Naylor et al., 2013). These authors speculate that 
this rapid upregulation represents a mechanism maintaining status epilepticus and leading to 
excitotoxic damage. We observed that all animals developed severe seizures lasting hours after 
the NMDA infusion. The increased expression of NMDA receptor subunits at earlier time points 
after lesion could therefore be the effect of seizure activity and not direct effect of NMDA. 
On the other hand, α5 subunit of GABAA receptor was significantly downregulated at 30 
dpi. GABAA receptors containing α5 subunit are localized preferentially extrasynaptically at 
pyramidal cells and generate a tonic conductance that regulates the excitability of pyramidal 
neurons in CA1 and CA3 regions of the hippocampus (Caraiscos et al., 2004). The loss of α5 
subunit immunoreactivity may therefore indicate loss of affected pyramidal cells. Since FJB 
staining indicates ongoing neurodegeneration by non-specific mechanism (change in intracellular 
pH), α5 immunohistochemistry might be more specific and sensitive approach to capture 
temporal progression of neurodegeneration of pyramidal cells. In another work, the 
immunoreactivity of this subunit was found to be decreased 30 days after kainate lesion in CA1, 
CA3 and hilus, the regions of cell loss (Bouilleret V. et al., 2000). On the other hand, the loss of 
α5 subunit on functional neurons may cause disinhibition of pyramidal neurons and shift the 
inhibitory/excitatory balance towards decreased excitability threshold.  
GABAA α2 subunit is expressed at majority of cells in hippocampus (Fritschy and Mohler, 
1995). Semi-quantitative analysis of GABAA α2 subunit did not show significant loss; however, 
we observed conspicuous loss at qualitative level in lesion-affected areas only where we found 
significant downregulation of α5 subunit. This supports the hypothesis that the loss of α5 subunit 
is connected to loss of pyramidal neuron rather than their downregulation in non affected 
neurons.  
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5. CONCLUSIONS 
Taken together, our data show that infusion of NMDA into hippocampal formation 
represents a model of focal, chronic neurodegeneration of principal neurons accompanied by 
severe neuroinflammation and changes in expression of NMDA receptor GluN1 and GluN2B 
subunits at an early stage and downregulation of GABAA receptor α5 subunit at 30 dpi. 
Surprisingly, GABAergic interneurons seem to be protected from NMDA excitotoxic action. We 
propose, that this model might be of interest to study chronic neurodegeneration and 
neuroinflammation, as well as the role of GABAergic interneurons during these processes. 
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TABLE AND FIGURE LEGENDS 
Table 1: List of primary antibodies, their manufacturers and dilutions used. 
Figure 1: Representative images of Fluoro-Jade B staining of dorsal ipsilateral hippocampus at 
1, 3, 7 and 30 dpi after the infusion of NMDA or PBS (1 dpi). Scale bar: A = 500 µm.  
Figure 2: Volumetric analysis of ipsilateral hippocampus did not reveal significant changes over 
30 days after NMDA infusion (P > 0.05). Values are given as mean ± SEM, (n = 5). 
 
Figure 3: Representative axial (left panel) and coronal (right panel) T2 weighted images of rat 
brain before and after infusion of NMDA into hippocampus. Figures illustrate the track of 
infusion cannula as well the extent of lesion up to 7 dpi. Infusion of NMDA increased the T2 
signal suggesting edema and inflammation in ipsilateral hippocampus. 
 
Figure 4: Unilateral (uni) infusion of NMDA (25 and 50 mM) did not induce spatial learning 
deficit measured as number of entrances into forbidden sector in the Carousel Maze. On the other 
hand, bilateral (bi) infusion induced significant spatial learning deficit (* p < 0.05, ** p < 0.01). 
Rats were tested 7 days after surgery in four consecutive sessions. The represented data are thus 
from day 11 after NMDA infusion. Values are given as mean ± SEM. 
 
Figure 5: Distribution of parvalbumin, neuropeptide Y, calbindin and calretinin 
immunoreactivity 1 day after PBS or NMDA injection into hippocampus. Scale bar = 500 µm. 
 
Figure 6: Representative images of immunoperoxidase staining using anti-Iba-1 antibody taken 
from the ipsilateral dorsal hippocampus at 1, 3, 7 or 30 dpi of NMDA or PBS (1 dpi). Scale bar: 
A = 500 µm. The chart in right bottom corner shows quantitative analysis of hippocampal anti-
Iba-1 immunoreactivity (IR) representing relative percentage of area covered by activated 
microglia. Values are given as mean ± SEM. ** P < 0.01, *** P < 0.001. 
 
Figure 7: Representative images of immunoperoxidase staining using anti-GFAP antibody taken 
from the ipsilateral dorsal hippocampus at 1, 3, 7 or 30 dpi of NMDA or PBS. Scale bar: A = 500 
µm. The chart in right bottom corner shows quantitative analysis of hippocampal anti-GFAP 
immunoreactivity (IR) representing relative percentage of area covered by astrocytes. Values are 
given as mean ± SEM. * P < 0.05, *** P < 0.001. 
 
Figure 8: Representative images of immunoperoxidase staining using anti-NMDA receptor 
GluN1 subunit antibody taken from the ipsilateral dorsal hippocampus at 1, 3, 7 or 30 dpi of 
NMDA or PBS (1 dpi). We did not observe significant changes in PBS injected hippocampus. 
NMDA lesion induced significant overexpression of NMDA receptor NR1 subunit in ipsilateral 
hippocampus at 1 and 3 dpi (P < 0.05). Scale bar: A = 500 µm. The chart in right bottom corner 
shows quantitative analysis of immunoperoxidase staining relative optical density. Values are 
given as mean ± SEM. * P < 0.05, ** P < 0.005. 
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Figure 9: Representative images of immunoperoxidase staining using anti-NMDA receptor 
GluN2B subunit antibody taken from the ipsilateral dorsal hippocampus at 1, 3, 7 or 30 dpi of 
NMDA or PBS (1 dpi). We did not observe significant changes in PBS injected hippocampus. 
NMDA lesion induced overexpression of NMDA receptor NR2B subunit in ipsilateral 
hippocampus (P < 0.05). The overexpression was significant at 1 and 3. The overexpression 
correlated with activation of microglia. Scale bar: A = 500 µm. The chart in right bottom corner 
shows quantitative analysis of immunoperoxidase staining relative optical density. Values are 
given as mean ± SEM. * P < 0.05, ** P < 0.005. 
 
Figure 10: Representative images of immunoperoxidase staining using anti-GABAA receptor α1 
subunit antibody taken from the ipsilateral dorsal hippocampus at 1, 3, 7 or 30 dpi of NMDA or 
PBS (1 dpi). We did not observe significant changes in PBS injected hippocampus. NMDA did 
not induce significant changes in α1 subunit expression (P > 0.05). We also did not observed loss 
of GABAA receptor α1 interneurons at any time-point. Scale bar: A = 500 µm. The chart in right 
bottom corner shows quantitative analysis of immunoperoxidase staining relative optical density. 
Values are given as mean ± SEM. 
 
Figure 11: Representative images of immunoperoxidase staining using anti-GABAA receptor α2 
subunit antibody taken from the ipsilateral dorsal hippocampus at 1, 3, 7 or 30 dpi of NMDA or 
PBS (1 dpi). We did not observe significant changes in PBS injected hippocampus. 
Quantification of relative optical density did not reveal significant changes between NMDA and 
PBS injected hippocampus (P > 0.05); however, we observed local loss of α2 subunit staining at 
days 7 and 30dpi that correlated with activation of microglia. Scale bar: A = 500 µm. The chart 
in right bottom corner shows quantitative analysis of immunoperoxidase staining relative optical 
density. Values are given as mean ± SEM. 
 
Figure 12: Representative images of immunoperoxidase staining using anti-GABAA receptor α5 
subunit antibody taken from the ipsilateral dorsal hippocampus at 1, 3, 7 or 30 dpi of NMDA or 
PBS (1 dpi). We did not observe significant changes in PBS injected hippocampus. NMDA 
induced progressive loss of α5 subunit expression. The expression was significantly different 
compare to PBS sham lesion at 30 dpi (P < 0.05). Scale bar: A = 500 µm. The chart in right 
bottom corner shows quantitative analysis of immunoperoxidase staining relative optical density. 
Values are given as mean ± SEM. * P < 0.05. 
 
Figure 13: Representative images of immunoperoxidase staining using anti-GABAA receptor γ2 
subunit antibody taken from the ipsilateral dorsal hippocampus at 1, 3, 7 or 30 dpi of NMDA or 
PBS (1 dpi). We did not observe significant changes in PBS injected hippocampus. 
Quantification of relative optical density did not reveal significant changes between NMDA and 
PBS injected hippocampus (P > 0.05). Scale bar: A = 500 µm. The chart in right bottom corner 
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shows quantitative analysis of immunoperoxidase staining relative optical density. Values are 
given as mean ± SEM. 
 
Supplementary Figure 1: Neural damage score after the NMDA lesion of hippocampus at 1, 3, 
7 and 30 dpi in CA1, CA3, dentate gyrus (DG), hilus and subiculum. No significant differences 
were observed among individual dpi. Sham lesion induced no damage (score 0, data not shown) 
Score scale: 0 – 0-5%, 1 – 6-25%, 2 – 26-50%, 3 – 51-75%, 4 > 75%. 
 
Supplementary Figure 2: Representative picture of dorsal hippocampus from the same animal 
demonstrating colocalization of the changes induced by unilateral infusion of NMDA at 30 dpi. 
Fluoro-Jade B, A = 500 µm; DAB stainings B = 500 µm. 
 
Supplementary Figure 3: Quantitative analysis of immunoperoxidase staining relative optical 
density in contralateral (intact) hippocampus. Statistical analysis did not reveal any difference 
between NMDA and PBS group (P > 0.05). Values are given as mean ± SEM. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Antibody Manufacturer Description/Nr. Dilution 
GABAAR α1 Fritschy and Möhler, 1995 Home-made guinea pig antiserum 1:20000 
GABAAR α2 Fritschy and Möhler, 1995 Home-made affinity-purified guinea pig 
antiserum 
1:1000 
GABAAR  α5 Fritschy and Möhler, 1995 Home-made Guinea pig antiserum 1:3000 
GABAAR γ2 Fritschy and Möhler, 1995 Home-made Guinea pig antiserum 1:15000 
NMDAR GluN1 NeuroMab, CA, USA Mouse monoclonal, clone N308/48 1:2000 
NMDAR GluN2B NeuroMab,CA, USA Mouse monoclonal, clone N59/36 1:2000 
Iba-1 Wako Rabbit polyclonal, 019-19741 1:4000 
GFAP Dako Schweiz AG, Switzerland Rabbit polyclonal, Z334 1:5000 
Parvalbumin SWant, Switzerland Rabbit polyclonal, PV-25 1:5000 
Calretinin SWant, Switzerland Rabbit serum, 7696 1:2000 
Calbindin SWant, Switzerland Rabbit serum, CB-38 1:3000 
NPY Peninsula Laboratories, USA Rabbit serum, T4069 1:1000 
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Figure 1A: Representative images of Fluoro-Jade B staining of dorsal ipsilateral hippocampus at 1, 3, 
7 or 30 dpi of NMDA or PBS (1 dpi). Scale bar: A = 500 µm.  
 
 Figure 1B: Volumetric analysis of ipsilateral hippocampus did not reveal significant changes over 30 
days after NMDA infusion (P > 0.05). Values are given as mean ± SEM, (n = 5). 
 
Figure 2: Representative coronal (left panel) and sagittal (right panel) T2 weighted images of rat brain 
before and after infusion of NMDA into hippocampus. Pictures illustrate the track of infusion cannula 
as well the extent of lesion up to 7 days post injection (dpi). Infusion of NMDA increased the T2 signal 
suggesting edema and inflammation in ipsilateral hippocampus. 
 
  
 
Figure 3: Unilateral infusion of NMDA (25 and 50 mM) did not induce spatial learning deficit 
measured as number of entrances into forbidden sector in Carousel Maze. On the other hand, bilateral 
infusion induced significant spatial learning deficit (* p < 0.05, ** p < 0.01). Rats were tested 7 days 
after surgery in four consecutive sessions. The represented data are thus from day 11 after NMDA 
infusion. Values are given as mean ± SEM. 
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Figure 4: Distribution of parvalbumin, neuropeptide Y (NPY), calbindin and calretinin 
immunoreactivity 1 day after PBS or NMDA injection into hippocampus. Scale bar: A = 500 µm. 
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Figure 5: A: Representative images of immunoperoxidase staining using anti-Iba-1 antibody taken 
from the ipsilateral dorsal hippocampus at 1, 3, 7 or 30 days post injection (dpi) of NMDA or PBS. 
Scale bar: A = 500 µm. B: Quantitative analysis of hippocampal anti-Iba-1 immunoreactivity (IR) 
representing relative percentage of area covered by activated microglia. Values are given as mean ± 
SEM. ** P < 0.01, *** P < 0.001, **** P < 0.0001. 
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Figure 6: A: Representative images of immunoperoxidase staining using anti-GFAP antibody taken 
from the ipsilateral dorsal hippocampus at 1, 3, 7 or 30 days post injection (dpi) of NMDA or PBS. 
Scale bar: A = 500 µm. B: Quantitative analysis of hippocampal anti-GFAP immunoreactivity (IR) 
representing relative percentage of area covered by astrocytes. Values are given as mean ± SEM. * P < 
0.05, *** P < 0.001, **** P < 0.0001. 
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Figure 7: A: Representative images of immunoperoxidase staining using anti-NMDA receptor NR1 
subunit antibody taken from the ipsilateral dorsal hippocampus at 1, 3, 7 or 30 days post injection (dpi) 
of NMDA. We did not observe significant changes in PBS injected hippocampus. NMDA lesion 
induced significant overexpression of NMDA receptor NR1 subunit in ipsilateral hippocampus at 1 a 3 
days post injection (dpi) of NMDA (P < 0.05). Scale bar: A = 500 µm. B: Quantitative analysis of 
immunoperoxidase staining relative optical density. Values are given as mean ± SEM. * P < 0.05, ** P 
< 0.005. 
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Figure 8: A: Representative images of immunoperoxidase staining using anti-NMDA receptor NR2B 
subunit antibody taken from the ipsilateral dorsal hippocampus at 1, 3, 7 or 30 days post injection (dpi) 
of NMDA. We did not observe significant changes in PBS injected hippocampus; therefore only one 
representative picture is shown. NMDA lesion induced overexpression of NMDA receptor NR2B 
subunit in ipsilateral hippocampus (P < 0.05). The overexpression was significant 1 a 3 days post 
injection (dpi) of NMDA. The overexpression correlated with activation of microglia. Scale bar: A = 
500 µm. B: Quantitative analysis of immunoperoxidase staining relative optical density. Values are 
given as mean ± SEM. * P < 0.05, ** P < 0.005. 
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Figure 9: A: Representative images of immunoperoxidase staining using anti-GABAA receptor α1 
subunit antibody taken from the ipsilateral dorsal hippocampus at 1, 3, 7 or 30 days post injection (dpi) 
of NMDA. We did not observe significant changes in PBS injected hippocampus. NMDA did not 
induce significant changes in α1 subunit expression (P > 0.05). We also did not observed loss of 
GABAA receptor α1 interneurons at any time-point. Scale bar: A = 500 µm. B: Quantitative analysis of 
immunoperoxidase staining relative optical density. Values are given as mean ± SEM. 
 
  
1 3 7 3 0
0
5 0
1 0 0
1 5 0
G A B A AR a1  ip s i
d p i
o
p
ti
c
a
l 
d
e
n
s
it
y
 (
A
U
)
NMDA
P B S
 
 
NMDA lesion 1dpi NMDA lesion 3dpi 
  
NMDA lesion 7dpi NMDA lesion 30dpi 
  
SHAM lesion (PBS)  
 
 
 
Figure 10: A: Representative images of immunoperoxidase staining using anti-GABAA receptor α2 
subunit antibody taken from the ipsilateral dorsal hippocampus at 1, 3, 7 or 30 days post injection (dpi) 
of NMDA. We did not observe significant changes in PBS injected hippocampus. Quantification of 
relative optical density did not reveal significant changes between NMDA and PBS injected 
hippocampus (P > 0.05); however, we observed local loss of α2 subunit staining at days 7 and 30dpi 
that correlated with activation of microglia. Scale bar: A = 500 µm. B: Quantitative analysis of 
immunoperoxidase staining relative optical density. Values are given as mean ± SEM. 
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Figure 11: A: Representative images of immunoperoxidase staining using anti-GABAA receptor α5 
subunit antibody taken from the ipsilateral dorsal hippocampus at 1, 3, 7 or 30 days post injection (dpi) 
of NMDA. We did not observe significant changes in PBS injected hippocampus. NMDA induced 
progressive loss of α5 subunit expression. The expression was significantly different compare to PBS 
sham lesion at 30 dpi (P < 0.05). Scale bar: A = 500 µm. B: Quantitative analysis of 
immunoperoxidase staining relative optical density. Values are given as mean ± SEM. * P < 0.05. 
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Figure 12: A: Representative images of immunoperoxidase staining using anti-GABAA receptor γ2 
subunit antibody taken from the ipsilateral dorsal hippocampus at 1, 3, 7 or 30 days post injection (dpi) 
of NMDA. We did not observe significant changes in PBS injected hippocampus. Quantification of 
relative optical density did not reveal significant changes between NMDA and PBS injected 
hippocampus (P > 0.05). Scale bar: A = 500 µm. B: Quantitative analysis of immunoperoxidase 
staining relative optical density. Values are given as mean ± SEM. 
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S1: Neural damage score after NMDA lesion of hippocampus 1, 3, 7 and 30 dpi in CA1, CA3, dentate 
gyrus (DG), hilus and subiculum. No significant differences were observed among individual days post 
injection. Sham lesion induced no damage (score 0, data not shown) Score scale: 0 – 0-5%, 1 – 6-25%, 
2 – 26-50%, 3 – 51-75%, 4 > 75%.  
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S2: Representative picture of dorsal hippocampus from the same animal demonstrating colocalization 
of the changes induced by unilateral infusion of NMDA at 30 dpi.   
 
 
 
 
 
 
S3: Quantitative analysis of immunoperoxidase staining relative optical density in contralateral (intact) 
hippocampus. Values for each hippocampus were normalized to neocortex. Statistical analysis did not 
reveal any difference between NMDA and PBS group (p < 0.05). Values are given as mean ± SEM. 
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